The effects of 5% Imiquimod cream on high-grade vulval intraepithelial neoplasia

Gynecologic Oncology

Volumn 85, Issue 1, 2002, Pages 67-70

  Todd, Richard W ^a   Etherington, Ian J ^a   Luesley, David M ^a  

^a BIRMINGHAM CHILDREN S HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IMIQUIMOD;

ADULT; ARTICLE; CANCER GRADING; CARCINOMA IN SITU; CLINICAL ARTICLE; CLINICAL TRIAL; CREAM; DRUG INDUCED DISEASE; ERYTHEMA; FEMALE; GYNECOLOGIC CANCER; HISTOLOGY; HUMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; TREATMENT OUTCOME; VULVA CARCINOMA; WART VIRUS;

EID: 0036230613     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.2001.6539     Document Type: Article

References (13)

1. Trends in squamous cell carcinoma of the vulva: The influence of vulvar intraepithelial neoplasia
2. Intraepithelial and invasive squamous cell neoplasia of the vulva: Trends in incidence, recurrence and survival in Norway
3. Vulvar intraepithelial neoplasia 3: A clinical study of the outcome in 113 cases with relation to the later development of invasive vulvar cancer
4. Vulvar intraepithelial neoplasia: Clinical review
5. Surgical approach to multifocal carcinoma in situ of the vulva
6. Management of carcinoma in situ of the vulva
7. Self administered topical 5% Imiquimod cream for external anogenital warts
8. Mechanism of action of Imiquimod
9. Immunological events in regressing genital warts
10. Human papillomavirus (HPV) in vulvar dysplasia and carcinoma in situ
11. Self administered topical Imiquimod treatment of vulvar intraepithelial neoplasia
12. Correlation between pretreatment levels of interferon response genes and clinical responses to an immune response modifier (Imiquimod) in genital warts